+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Competent Cells Market by Application, Cell Type, End User, Product Offerings, Technology - Global Forecast 2025-2030- Product Image
Competent Cells Market by Application, Cell Type, End User, Product Offerings, Technology - Global Forecast 2025-2030- Product Image
Sale

Competent Cells Market by Application, Cell Type, End User, Product Offerings, Technology - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 197 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 6014488
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Competent Cells Market grew from USD 2.01 billion in 2023 to USD 2.21 billion in 2024. It is expected to continue growing at a CAGR of 8.76%, reaching USD 3.62 billion by 2030.

Competent cells are defined as cells that have been modified to absorb foreign DNA seamlessly, crucial for molecular cloning, genetic transformations, and various research applications in biotechnology and genetic engineering. This market is driven by the rising demand for biotechnology-based products, increased focus on research and development activities, and advancements in synthetic biology. Its application spans across pharmaceutical and biotechnology companies, academic institutions, and research laboratories, with end-use sectors focusing heavily on areas like drug discovery, DNA fingerprinting, and protein expression. A key influencing factor in market growth is the expanding biopharmaceutical industry, which propels the demand for genetic modifications and molecular research techniques coupled with government funding initiatives in life sciences research. Potential opportunities lie in the expansion of CRISPR technology applications, increased utilization in plant genetic engineering, and the shift toward creating more efficient cell lines for therapeutic protein production. However, limitations such as high costs of competent cell kits and challenges in transformation efficiency remain significant barriers. Moreover, regulatory issues concerning genetic engineering and ethical concerns also pose challenges to market expansion. Innovations in automation for competent cell preparation, development of cost-effective and high-efficiency competent cells, and enhancements in genome editing tools present promising avenues for business growth. The market's nature is highly dynamic and competitive, characterized by rapid technological advancements and a strong emphasis on collaboration between commercial entities and research institutions. For businesses to capitalize on growth, strategic partnerships and investments in research and development are essential, with a focus on developing customizable solutions for diversified applications. Engaging in extensive market research would also help align product offerings with emerging trends and customer needs, enabling significant competitive leverage and sustainable growth within the competent cells market.

Understanding Market Dynamics in the Competent Cells Market

The Competent Cells Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • increased application of competent cells in gene therapy and personalized medicine
    • rising prevalence of chronic diseases necessitating advanced research using competent cells
    • development of new competent cell strains with enhanced transformation efficiency
    • growing collaborations between research institutions and biotechnology companies to improve cell technologies
  • Market Restraints
    • Limited efficiency in transformation of some competent cell strains imposing constraints on usage in complex genetic experiments
    • High costs associated with production and storage of competent cells hindering small-scale and academic research applications
  • Market Opportunities
    • Enhancing the efficiency and yield of competent cells for industrial-scale biotechnology processes
    • Market potential in expanding agricultural biotechnology with high-performance competent cells
    • Applications of competent cells in environmental biotechnology for pollution control and bio-remediation
  • Market Challenges
    • Regulatory hurdles in approval and commercialization of genetically modified organisms (GMOs) created using competent cells
    • Ethical concerns and public perception issues regarding genetic modifications facilitated by competent cell technologies

Exploring Porter’s Five Forces for the Competent Cells Market

Porter’s Five Forces framework further strengthens the insights of the Competent Cells Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Competent Cells Market

External macro-environmental factors deeply influence the performance of the Competent Cells Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Competent Cells Market

The Competent Cells Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Competent Cells Market

The Competent Cells Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Competent Cells Market

The Competent Cells Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Competent Cells Market, highlighting leading vendors and their innovative profiles. These include Addgene, Agilent Technologies, Bio-Rad Laboratories, BioDynamics Laboratory, Bioneer Corporation, Cayman Chemical Company, Cell Applications, Edge BioSystems, GenScript Biotech, Lucigen Corporation, Merck Group, New England Biolabs, OriGene Technologies, Promega Corporation, QIAGEN, Scarab Genomics, Takara Bio, Thermo Fisher Scientific, Yeastern Biotech, and Zymo Research.

Market Segmentation & Coverage

This research report categorizes the Competent Cells Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Application
    • Biotechnology
      • Genetic Engineering
      • Protein Expression
    • Clinical Research
      • Diagnostics
      • Therapeutic Development
    • Industrial
      • Bioconversion
      • Fermentation
    • Pharmaceutical
      • Drug Discovery
      • Vaccine Development
    • Research and Development
      • Bioinformatics
      • Microbiology
      • Molecular Biology
  • Cell Type
    • E. coli Competent Cells
      • Chemically Competent E. coli
      • Electrocompetent E. coli
    • Mammalian Competent Cells
      • CHO Cells
      • HEK Cells
    • Other Bacterial Competent Cells
      • B. subtilis
      • L. lactis
    • Yeast Competent Cells
      • P. pastoris
      • S. cerevisiae
  • End User
    • Academic and Research Institutes
      • Non-profit Research Centers
      • Universities
    • Agricultural Research Organizations
    • Biotech Companies
      • Established Biotechs
      • Startup Biotechs
    • Contract Research Organizations
    • Pharmaceutical Companies
  • Product Offerings
    • Competent Cell Kits
      • Chemical Transformation Kits
      • Electroporation Kits
    • Reagents and Consumables
      • Antibiotics
      • Growth Media
      • Plasmids
    • Services
      • Custom Cloning Services
      • Custom Protein Expression Services
  • Technology
    • Chemical Transformation
    • Electroporation
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. increased application of competent cells in gene therapy and personalized medicine
5.1.1.2. rising prevalence of chronic diseases necessitating advanced research using competent cells
5.1.1.3. development of new competent cell strains with enhanced transformation efficiency
5.1.1.4. growing collaborations between research institutions and biotechnology companies to improve cell technologies
5.1.2. Restraints
5.1.2.1. Limited efficiency in transformation of some competent cell strains imposing constraints on usage in complex genetic experiments
5.1.2.2. High costs associated with production and storage of competent cells hindering small-scale and academic research applications
5.1.3. Opportunities
5.1.3.1. Enhancing the efficiency and yield of competent cells for industrial-scale biotechnology processes
5.1.3.2. Market potential in expanding agricultural biotechnology with high-performance competent cells
5.1.3.3. Applications of competent cells in environmental biotechnology for pollution control and bio-remediation
5.1.4. Challenges
5.1.4.1. Regulatory hurdles in approval and commercialization of genetically modified organisms (GMOs) created using competent cells
5.1.4.2. Ethical concerns and public perception issues regarding genetic modifications facilitated by competent cell technologies
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Competent Cells Market, by Application
6.1. Introduction
6.2. Biotechnology
6.2.1. Genetic Engineering
6.2.2. Protein Expression
6.3. Clinical Research
6.3.1. Diagnostics
6.3.2. Therapeutic Development
6.4. Industrial
6.4.1. Bioconversion
6.4.2. Fermentation
6.5. Pharmaceutical
6.5.1. Drug Discovery
6.5.2. Vaccine Development
6.6. Research and Development
6.6.1. Bioinformatics
6.6.2. Microbiology
6.6.3. Molecular Biology
7. Competent Cells Market, by Cell Type
7.1. Introduction
7.2. E. coli Competent Cells
7.2.1. Chemically Competent E. coli
7.2.2. Electrocompetent E. coli
7.3. Mammalian Competent Cells
7.3.1. CHO Cells
7.3.2. HEK Cells
7.4. Other Bacterial Competent Cells
7.4.1. B. subtilis
7.4.2. L. lactis
7.5. Yeast Competent Cells
7.5.1. P. pastoris
7.5.2. S. cerevisiae
8. Competent Cells Market, by End User
8.1. Introduction
8.2. Academic and Research Institutes
8.2.1. Non-profit Research Centers
8.2.2. Universities
8.3. Agricultural Research Organizations
8.4. Biotech Companies
8.4.1. Established Biotechs
8.4.2. Startup Biotechs
8.5. Contract Research Organizations
8.6. Pharmaceutical Companies
9. Competent Cells Market, by Product Offerings
9.1. Introduction
9.2. Competent Cell Kits
9.2.1. Chemical Transformation Kits
9.2.2. Electroporation Kits
9.3. Reagents and Consumables
9.3.1. Antibiotics
9.3.2. Growth Media
9.3.3. Plasmids
9.4. Services
9.4.1. Custom Cloning Services
9.4.2. Custom Protein Expression Services
10. Competent Cells Market, by Technology
10.1. Introduction
10.2. Chemical Transformation
10.3. Electroporation
11. Americas Competent Cells Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Competent Cells Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Competent Cells Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. Market Share Analysis, 2023
14.2. FPNV Positioning Matrix, 2023
14.3. Competitive Scenario Analysis
14.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. COMPETENT CELLS MARKET RESEARCH PROCESS
FIGURE 2. COMPETENT CELLS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL COMPETENT CELLS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL COMPETENT CELLS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL COMPETENT CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL COMPETENT CELLS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 7. GLOBAL COMPETENT CELLS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL COMPETENT CELLS MARKET SIZE, BY CELL TYPE, 2023 VS 2030 (%)
FIGURE 9. GLOBAL COMPETENT CELLS MARKET SIZE, BY CELL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL COMPETENT CELLS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 11. GLOBAL COMPETENT CELLS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL COMPETENT CELLS MARKET SIZE, BY PRODUCT OFFERINGS, 2023 VS 2030 (%)
FIGURE 13. GLOBAL COMPETENT CELLS MARKET SIZE, BY PRODUCT OFFERINGS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL COMPETENT CELLS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 15. GLOBAL COMPETENT CELLS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. AMERICAS COMPETENT CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. AMERICAS COMPETENT CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. UNITED STATES COMPETENT CELLS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 19. UNITED STATES COMPETENT CELLS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. ASIA-PACIFIC COMPETENT CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. ASIA-PACIFIC COMPETENT CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA COMPETENT CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA COMPETENT CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 24. COMPETENT CELLS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 25. COMPETENT CELLS MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. COMPETENT CELLS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL COMPETENT CELLS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL COMPETENT CELLS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL COMPETENT CELLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. COMPETENT CELLS MARKET DYNAMICS
TABLE 7. GLOBAL COMPETENT CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL COMPETENT CELLS MARKET SIZE, BY BIOTECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL COMPETENT CELLS MARKET SIZE, BY GENETIC ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL COMPETENT CELLS MARKET SIZE, BY PROTEIN EXPRESSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL COMPETENT CELLS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL COMPETENT CELLS MARKET SIZE, BY CLINICAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL COMPETENT CELLS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL COMPETENT CELLS MARKET SIZE, BY THERAPEUTIC DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL COMPETENT CELLS MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL COMPETENT CELLS MARKET SIZE, BY INDUSTRIAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL COMPETENT CELLS MARKET SIZE, BY BIOCONVERSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL COMPETENT CELLS MARKET SIZE, BY FERMENTATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL COMPETENT CELLS MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL COMPETENT CELLS MARKET SIZE, BY PHARMACEUTICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL COMPETENT CELLS MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL COMPETENT CELLS MARKET SIZE, BY VACCINE DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL COMPETENT CELLS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL COMPETENT CELLS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL COMPETENT CELLS MARKET SIZE, BY BIOINFORMATICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL COMPETENT CELLS MARKET SIZE, BY MICROBIOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL COMPETENT CELLS MARKET SIZE, BY MOLECULAR BIOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL COMPETENT CELLS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL COMPETENT CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL COMPETENT CELLS MARKET SIZE, BY E. COLI COMPETENT CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL COMPETENT CELLS MARKET SIZE, BY CHEMICALLY COMPETENT E. COLI, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL COMPETENT CELLS MARKET SIZE, BY ELECTROCOMPETENT E. COLI, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL COMPETENT CELLS MARKET SIZE, BY E. COLI COMPETENT CELLS, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL COMPETENT CELLS MARKET SIZE, BY MAMMALIAN COMPETENT CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL COMPETENT CELLS MARKET SIZE, BY CHO CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL COMPETENT CELLS MARKET SIZE, BY HEK CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL COMPETENT CELLS MARKET SIZE, BY MAMMALIAN COMPETENT CELLS, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL COMPETENT CELLS MARKET SIZE, BY OTHER BACTERIAL COMPETENT CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL COMPETENT CELLS MARKET SIZE, BY B. SUBTILIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL COMPETENT CELLS MARKET SIZE, BY L. LACTIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL COMPETENT CELLS MARKET SIZE, BY OTHER BACTERIAL COMPETENT CELLS, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL COMPETENT CELLS MARKET SIZE, BY YEAST COMPETENT CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL COMPETENT CELLS MARKET SIZE, BY P. PASTORIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL COMPETENT CELLS MARKET SIZE, BY S. CEREVISIAE, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL COMPETENT CELLS MARKET SIZE, BY YEAST COMPETENT CELLS, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL COMPETENT CELLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL COMPETENT CELLS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL COMPETENT CELLS MARKET SIZE, BY NON-PROFIT RESEARCH CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL COMPETENT CELLS MARKET SIZE, BY UNIVERSITIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL COMPETENT CELLS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL COMPETENT CELLS MARKET SIZE, BY AGRICULTURAL RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL COMPETENT CELLS MARKET SIZE, BY BIOTECH COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL COMPETENT CELLS MARKET SIZE, BY ESTABLISHED BIOTECHS, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL COMPETENT CELLS MARKET SIZE, BY STARTUP BIOTECHS, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL COMPETENT CELLS MARKET SIZE, BY BIOTECH COMPANIES, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL COMPETENT CELLS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL COMPETENT CELLS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL COMPETENT CELLS MARKET SIZE, BY PRODUCT OFFERINGS, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL COMPETENT CELLS MARKET SIZE, BY COMPETENT CELL KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL COMPETENT CELLS MARKET SIZE, BY CHEMICAL TRANSFORMATION KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL COMPETENT CELLS MARKET SIZE, BY ELECTROPORATION KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL COMPETENT CELLS MARKET SIZE, BY COMPETENT CELL KITS, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL COMPETENT CELLS MARKET SIZE, BY REAGENTS AND CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL COMPETENT CELLS MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL COMPETENT CELLS MARKET SIZE, BY GROWTH MEDIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL COMPETENT CELLS MARKET SIZE, BY PLASMIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL COMPETENT CELLS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL COMPETENT CELLS MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL COMPETENT CELLS MARKET SIZE, BY CUSTOM CLONING SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL COMPETENT CELLS MARKET SIZE, BY CUSTOM PROTEIN EXPRESSION SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL COMPETENT CELLS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL COMPETENT CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL COMPETENT CELLS MARKET SIZE, BY CHEMICAL TRANSFORMATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL COMPETENT CELLS MARKET SIZE, BY ELECTROPORATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS COMPETENT CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS COMPETENT CELLS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS COMPETENT CELLS MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS COMPETENT CELLS MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS COMPETENT CELLS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS COMPETENT CELLS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS COMPETENT CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS COMPETENT CELLS MARKET SIZE, BY E. COLI COMPETENT CELLS, 2018-2030 (USD MILLION)
TABLE 83. AMERICAS COMPETENT CELLS MARKET SIZE, BY MAMMALIAN COMPETENT CELLS, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS COMPETENT CELLS MARKET SIZE, BY OTHER BACTERIAL COMPETENT CELLS, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS COMPETENT CELLS MARKET SIZE, BY YEAST COMPETENT CELLS, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS COMPETENT CELLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 87. AMERICAS COMPETENT CELLS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 88. AMERICAS COMPETENT CELLS MARKET SIZE, BY BIOTECH COMPANIES, 2018-2030 (USD MILLION)
TABLE 89. AMERICAS COMPETENT CELLS MARKET SIZE, BY PRODUCT OFFERINGS, 2018-2030 (USD MILLION)
TABLE 90. AMERICAS COMPETENT CELLS MARKET SIZE, BY COMPETENT CELL KITS, 2018-2030 (USD MILLION)
TABLE 91. AMERICAS COMPETENT CELLS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 92. AMERICAS COMPETENT CELLS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 93. AMERICAS COMPETENT CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 94. AMERICAS COMPETENT CELLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 95. ARGENTINA COMPETENT CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA COMPETENT CELLS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 97. ARGENTINA COMPETENT CELLS MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 98. ARGENTINA COMPETENT CELLS MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
TABLE 99. ARGENTINA COMPETENT CELLS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 100. ARGENTINA COMPETENT CELLS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 101. ARGENTINA COMPETENT CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 102. ARGENTINA COMPETENT CELLS MARKET SIZE, BY E. COLI COMPETENT CELLS, 2018-2030 (USD MILLION)
TABLE 103. ARGENTINA COMPETENT CELLS MARKET SIZE, BY MAMMALIAN COMPETENT CELLS, 2018-2030 (USD MILLION)
TABLE 104. ARGENTINA COMPETENT CELLS MARKET SIZE, BY OTHER BACTERIAL COMPETENT CELLS, 2018-2030 (USD MILLION)
TABLE 105. ARGENTINA COMPETENT CELLS MARKET SIZE, BY YEAST COMPETENT CELLS, 2018-2030 (USD MILLION)
TABLE 106. ARGENTINA COMPETENT CELLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 107. ARGENTINA COMPETENT CELLS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 108. ARGENTINA COMPETENT CELLS MARKET SIZE, BY BIOTECH COMPANIES, 2018-2030 (USD MILLION)
TABLE 109. ARGENTINA COMPETENT CELLS MARKET SIZE, BY PRODUCT OFFERINGS, 2018-2030 (USD MILLION)
TABLE 110. ARGENTINA COMPETENT CELLS MARKET SIZE, BY COMPETENT CELL KITS, 2018-2030 (USD MILLION)
TABLE 111. ARGENTINA COMPETENT CELLS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 112. ARGENTINA COMPETENT CELLS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 113. ARGENTINA COMPETENT CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 114. BRAZIL COMPETENT CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 115. BRAZIL COMPETENT CELLS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 116. BRAZIL COMPETENT CELLS MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 117. BRAZIL COMPETENT CELLS MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
TABLE 118. BRAZIL COMPETENT CELLS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 119. BRAZIL COMPETENT CELLS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 120. BRAZIL COMPETENT CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 121. BRAZIL COMPETENT CELLS MARKET SIZE, BY E. COLI COMPETENT CELLS, 2018-2030 (USD MILLION)
TABLE 122. BRAZIL COMPETENT CELLS MARKET SIZE, BY MAMMALIAN COMPETENT CELLS, 2018-2030 (USD MILLION)
TABLE 123. BRAZIL COMPETENT CELLS MARKET SIZE, BY OTHER BACTERIAL COMPETENT CELLS, 2018-2030 (USD MILLION)
TABLE 124. BRAZIL COMPETENT CELLS MARKET SIZE, BY YEAST COMPETENT CELLS, 2018-2030 (USD MILLION)
TABLE 125. BRAZIL COMPETENT CELLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 126. BRAZIL COMPETENT CELLS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 127. BRAZIL COMPETENT CELLS MARKET SIZE, BY BIOTECH COMPANIES, 2018-2030 (USD MILLION)
TABLE 128. BRAZIL COMPETENT CELLS MARKET SIZE, BY PRODUCT OFFERINGS, 2018-2030 (USD MILLION)
TABLE 129. BRAZIL COMPETENT CELLS MARKET SIZE, BY COMPETENT CELL KITS, 2018-2030 (USD MILLION)
TABLE 130. BRAZIL COMPETENT CELLS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 131. BRAZIL COMPETENT CELLS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 132. BRAZIL COMPETENT CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 133. CANADA COMPETENT CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 134. CANADA COMPETENT CELLS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 135. CANADA COMPETENT CELLS MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 136. CANADA COMPETENT CELLS MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
TABLE 137. CANADA COMPETENT CELLS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 138. CANADA COMPETENT CELLS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 139. CANADA COMPETENT CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 140. CANADA COMPETENT CELLS MARKET SIZE, BY E. COLI COMPETENT CELLS, 2018-2030 (USD MILLION)
TABLE 141. CANADA COMPETENT CELLS MARKET SIZE, BY MAMMALIAN COMPETENT CELLS, 2018-2030 (USD MILLION)
TABLE 142. CANADA COMPETENT CELLS MARKET SIZE, BY OTHER BACTERIAL COMPETENT CELLS, 2018-2030 (USD MILLION)
TABLE 143. CANADA COMPETENT CELLS MARKET SIZE, BY YEAST COMPETENT CELLS, 2018-2030 (USD MILLION)
TABLE 144. CANADA COMPETENT CELLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 145. CANADA COMPETENT CELLS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 146. CANADA COMPETENT CELLS MARKET SIZE, BY BIOTECH COMPANIES, 2018-2030 (USD MILLION)
TABLE 147. CANADA COMPETENT CELLS MARKET SIZE, BY PRODUCT OFFERINGS, 2018-2030 (USD MILLION)
TABLE 148. CANADA COMPETENT CELLS MARKET SIZE, BY COMPETENT CELL KITS, 2018-2030 (USD MILLION)
TABLE 149. CANADA COMPETENT CELLS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 150. CANADA COMPETENT CELLS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 151. CANADA COMPETENT CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 152. MEXICO COMPETENT CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 153. MEXICO COMPETENT CELLS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 154. MEXICO COMPETENT CELLS MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 155. MEXICO COMPETENT CELLS MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
TABLE 156. MEXICO COMPETENT CELLS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 157. MEXICO COMPETENT CELLS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 158. MEXICO COMPETENT CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 159. MEXICO COMPETENT CELLS MARKET SIZE, BY E. COLI COMPETENT CELLS, 2018-2030 (USD MILLION)
TABLE 160. MEXICO COMPETENT CELLS MARKET SIZE, BY MAMMALIAN COMPETENT CELLS, 2018-2030 (USD MILLION)
TABLE 161. MEXICO COMPETENT CELLS MARKET SIZE, BY OTHER BACTERIAL COMPETENT CELLS, 2018-2030 (USD MILLION)
TABLE 162. MEXICO COMPETENT CELLS MARKET SIZE, BY YEAST COMPETENT CELLS, 2018-2030 (USD MILLION)
TABLE 163. MEXICO COMPETENT CELLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 164. MEXICO COMPETENT CELLS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 165. MEXICO COMPETENT CELLS MARKET SIZE, BY BIOTECH COMPANIES, 2018-2030 (USD MILLION)
TABLE 166. MEXICO COMPETENT CELLS MARKET SIZE, BY PRODUCT OFFERINGS, 2018-2030 (USD MILLION)
TABLE 167. MEXICO COMPETENT CELLS MARKET SIZE, BY COMPETENT CELL KITS, 2018-2030 (USD MILLION)
TABLE 168. MEXICO COMPETENT CELLS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 169. MEXICO COMPETENT CELLS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 170. MEXICO COMPETENT CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 171. UNITED STATES COMPETENT CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 172. UNITED STATES COMPETENT CELLS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 173. UNITED STATES COMPETENT CELLS MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 174. UNITED STATES COMPETENT CELLS MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
TABLE 175. UNITED STATES COMPETENT CELLS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 176. UNITED STATES COMPETENT CELLS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 177. UNITED STATES COMPETENT CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 178. UNITED STATES COMPETENT CELLS MARKET SIZE, BY E. COLI COMPETENT CELLS, 2018-2030 (USD MILLION)
TABLE 179. UNITED STATES COMPETENT CELLS MARKET SIZE, BY MAMMALIAN COMPETENT CELLS, 2018-2030 (USD MILLION)
TABLE 180. UNITED STATES COMPETENT CELLS MARKET SIZE, BY OTHER BACTERIAL COMPETENT CELLS, 2018-2030 (USD MILLION)
TABLE 181. UNITED STATES COMPETENT CELLS MARKET SIZE, BY YEAST COMPETENT CELLS, 2018-2030 (USD MILLION)
TABLE 182. UNITED STATES COMPETENT CELLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 183. UNITED STATES COMPETENT CELLS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 184. UNITED STATES COMPETENT CELLS MARKET SIZE, BY BIOTECH COMPANIES, 2018-2030 (USD MILLION)
TABLE 185. UNITED STATES COMPETENT CELLS MARKET SIZE, BY PRODUCT OFFERINGS, 2018-2030 (USD MILLION)
TABLE 186. UNITED STATES COMPETENT CELLS MARKET SIZE, BY COMPETENT CELL KITS, 2018-2030 (USD MILLION)
TABLE 187. UNITED STATES COMPETENT CELLS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 188. UNITED STATES COMPETENT CELLS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 189. UNITED STATES COMPETENT CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 190. UNITED STATES COMPETENT CELLS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 191. ASIA-PACIFIC COMPETENT CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 192. ASIA-PACIFIC COMPETENT CELLS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 193. ASIA-PACIFIC COMPETENT CELLS MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 194. ASIA-PACIFIC COMPETENT CELLS MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
TABLE 195. ASIA-PACIFIC COMPETENT CELLS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 196. ASIA-PACIFIC COMPETENT CELLS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 197. ASIA-PACIFIC COMPETENT CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 198. ASIA-PACIFIC COMPETENT CELLS MARKET SIZE, BY E. COLI COMPETENT CELLS, 2018-2030 (USD MILLION)
TABLE 199. ASIA-PACIFIC COMPETENT CELLS MARKET SIZE, BY MAMMALIAN COMPETENT CELLS, 2018-2030 (USD MILLION)
TABLE 200. ASIA-PACIFIC COMPETENT CELLS MARKET SIZE, BY OTHER BACTERIAL COMPETENT CELLS, 2018-2030 (USD MILLION)
TABLE 201. ASIA-PACIFIC COMPETENT CELLS MARKET SIZE, BY YEAST COMPETENT CELLS, 2018-2030 (USD MILLION)
TABLE 202. ASIA-PACIFIC COMPETENT CELLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 203. ASIA-PACIFIC COMPETENT CELLS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 204. ASIA-PACIFIC COMPETENT CELLS MARKET SIZE, BY BIOTECH COMPANIES, 2018-2030 (USD MILLION)
TABLE 205. ASIA-PACIFIC COMPETENT CELLS MARKET SIZE, BY PRODUCT OFFERINGS, 2018-2030 (USD MILLION)
TABLE 206. ASIA-PACIFIC COMPETENT CELLS MARKET SIZE, BY COMPETENT CELL KITS, 2018-2030 (USD MILLION)
TABLE 207. ASIA-PACIFIC COMPETENT CELLS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 208. ASIA-PACIFIC COMPETENT CELLS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 209. ASIA-PACIFIC COMPETENT CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 210. ASIA-PACIFIC COMPETENT CELLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 211. AUSTRALIA COMPETENT CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 212. AUSTRALIA COMPETENT CELLS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 213. AUSTRALIA COMPETENT CELLS MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 214. AUSTRALIA COMPETENT CELLS MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
TABLE 215. AUSTRALIA COMPETENT CELLS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 216. AUSTRALIA COMPETENT CELLS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 217. AUSTRALIA COMPETENT CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 218. AUSTRALIA COMPETENT CELLS MARKET SIZE, BY E. COLI COMPETENT CELLS, 2018-2030 (USD MILLION)
TABLE 219. AUSTRALIA COMPETENT CELLS MARKET SIZE, BY MAMMALIAN COMPETENT CELLS, 2018-2030 (USD MILLION)
TABLE 220. AUSTRALIA COMPETENT CELLS MARKET SIZE, BY OTHER BACTERIAL COMPETENT CELLS, 2018-2030 (USD MILLION)
TABLE 221. AUSTRALIA COMPETENT CELLS MARKET SIZE, BY YEAST COMPETENT CELLS, 2018-2030 (USD MILLION)
TABLE 222. AUSTRALIA COMPETENT CELLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 223. AUSTRALIA COMPETENT CELLS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 224. AUSTRALIA COMPETENT CELLS MARKET SIZE, BY BIOTECH COMPANIES, 2018-2030 (USD MILLION)
TABLE 225. AUSTRALIA COMPETENT CELLS MARKET SIZE, BY PRODUCT OFFERINGS, 2018-2030 (USD MILLION)
TABLE 226. AUSTRALIA COMPETENT CELLS MARKET SIZE, BY COMPETENT CELL KITS, 2018-2030 (USD MILLION)
TABLE 227. AUSTRALIA COMPETENT CELLS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 228. AUSTRALIA COMPETENT CELLS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 229. AUSTRALIA COMPETENT CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 230. CHINA COMPETENT CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 231. CHINA COMPETENT CELLS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 232. CHINA COMPETENT CELLS MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 233. CHINA COMPETENT CELLS MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
TABLE 234. CHINA COMPETENT CELLS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 235. CHINA COMPETENT CELLS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 236. CHINA COMPETENT CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 237. CHINA COMPETENT CELLS MARKET SIZE, BY E. COLI COMPETENT CELLS, 2018-2030 (USD MILLION)
TABLE 238. CHINA COMPETENT CELLS MARKET SIZE, BY MAMMALIAN COMPETENT CELLS, 2018-2030 (USD MILLION)
TABLE 239. CHINA COMPETENT CELLS MARKET SIZE, BY OTHER BACTERIAL COMPETENT CELLS, 2018-2030 (USD MILLION)
TABLE 240. CHINA COMPETENT CELLS MARKET SIZE, BY YEAST COMPETENT CELLS, 2018-2030 (USD MILLION)
TABLE 241. CHINA COMPETENT CELLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 242. CHINA COMPETENT CELLS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 243. CHINA COMPETENT CELLS MARKET SIZE, BY BIOTECH COMPANIES, 2018-2030 (USD MILLION)
TABLE 244. CHINA COMPETENT CELLS MARKET SIZE, BY PRODUCT OFFERINGS, 2018-2030 (USD MILLION)
TABLE 245. CHINA COMPETENT CELLS MARKET SIZE, BY COMPETENT CELL KITS, 2018-2030 (USD MILLION)
TABLE 246. CHINA COMPETENT CELLS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 247. CHINA COMPETENT CELLS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 248. CHINA COMPETENT CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 249. INDIA COMPETENT CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 250. INDIA COMPETENT CELLS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 251. INDIA COMPETENT CELLS MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 252. INDIA COMPETENT CELLS MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
TABLE 253. INDIA COMPETENT CELLS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 254. INDIA COMPETENT CELLS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 255. INDIA COMPETENT CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 256. INDIA COMPETENT CELLS MARKET SIZE, BY E. COLI COMPETENT CELLS, 2018-2030 (USD MILLION)
TABLE 257. INDIA COMPETENT CELLS MARKET SIZE, BY MAMMALIAN COMPETENT CELLS, 2018-2030 (USD MILLION)
TABLE 258. INDIA COMPETENT CELLS MARKET SIZE, BY OTHER BACTERIAL COMPETENT CELLS, 2018-2030 (USD MILLION)
TABLE 259. INDIA COMPETENT CELLS MARKET SIZE, BY YEAST COMPETENT CELLS, 2018-2030 (USD MILLION)
TABLE 260. INDIA COMPETENT CELLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 261. INDIA COMPETENT CELLS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 262. INDIA COMPETENT CELLS MARKET SIZE, BY BIOTECH COMPANIES, 2018-2030 (USD MILLION)
TABLE 263. INDIA COMPETENT CELLS MARKET SIZE, BY PRODUCT OFFERINGS, 2018-2030 (USD MILLION)
TABLE 264. INDIA COMPETENT CELLS MARKET SIZE, BY COMPETENT CELL KITS, 2018-2030 (USD MILLION)
TABLE 265. INDIA COMPETENT CELLS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 266. INDIA COMPETENT CELLS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 267. INDIA COMPETENT CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 268. INDONESIA COMPETENT CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 269. INDONESIA COMPETENT CELLS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 270. INDONESIA COMPETENT CELLS MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 271. INDONESIA COMPETENT CELLS MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
TABLE 272. INDONESIA COMPETENT CELLS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 273. INDONESIA COMPETENT CELLS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 274. INDONESIA COMPETENT CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 275. INDONESIA COMPETENT CELLS MARKET SIZE, BY E. COLI COMPETENT CELLS, 2018-2030 (USD MILLION)
TABLE 276. INDONESIA COMPETENT CELLS MARKET SIZE, BY MAMMALIAN COMPETENT CELLS, 2018-2030 (USD MILLION)
TABLE 277. INDONESIA COMPETENT CELLS MARKET SIZE, BY OTHER BACTERIAL COMPETENT CELLS, 2018-2030 (USD MILLION)
TABLE 278. INDONESIA COMPETENT CELLS MARKET SIZE, BY YEAST COMPETENT CELLS, 2018-2030 (USD MILLION)
TABLE 279. INDONESIA COMPETENT CELLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 280. INDONESIA COMPETENT CELLS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 281. INDONESIA COMPETENT CELLS MARKET SIZE, BY BIOTECH COMPANIES, 2018-2030 (USD MILLION)
TABLE 282. INDONESIA COMPETENT CELLS MARKET SIZE, BY PRODUCT OFFERINGS, 2018-2030 (USD MILLION)
TABLE 283. INDONESIA COMPETENT CELLS MARKET SIZE, BY COMPETENT CELL KITS, 2018-2030 (USD MILLION)
TABLE 284. INDONESIA COMPETENT CELLS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 285. INDONESIA COMPETENT CELLS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 286. INDONESIA COMPETENT CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 287. JAPAN COMPETENT CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 288. JAPAN COMPETENT CELLS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 289. JAPAN COMPETENT CELLS MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 290. JAPAN COMPETENT CELLS MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
TABLE 291. JAPAN COMPETENT CELLS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 292. JAPAN COMPETENT CELLS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 293. JAPAN COMPETENT CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 294. JAPAN COMPETENT CELLS MARKET SIZE, BY E. COLI COMPETENT CELLS, 2018-2030 (USD MILLION)
TABLE 295. JAPAN COMPETENT CELLS MARKET SIZE, BY MAMMALIAN COMPETENT CELLS, 2018-2030 (USD MILLION)
TABLE 296. JAPAN COMPETENT CELLS MARKET SIZE, BY OTHER BACTERIAL COMPETENT CELLS, 2018-2030 (USD MILLION)
TABLE 297. JAPAN COMPETENT CELLS MARKET SIZE, BY YEAST COMPETENT CELLS, 2018-2030 (USD MILLION)
TABLE 298. JAPAN COMPETENT CELLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 299. JAPAN COMPETENT CELLS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 300. JAPAN COMPETENT CELLS MARKET SIZE, BY BIOTECH COMPANIES, 2018-2030 (USD MILLION)
TABLE 301. JAPAN COMPETENT CELLS MARKET SIZE, BY PRODUCT OFFERINGS, 2018-2030 (USD MILLION)
TABLE 302. JAPAN COMPETENT CELLS MARKET SIZE, BY COMPETENT CELL KITS, 2018-2030 (USD MILLION)
TABLE 303. JAPAN COMPETENT CELLS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 304. JAPAN COMPETENT CELLS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 305. JAPAN COMPETENT CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 306. MALAYSIA COMPETENT CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 307. MALAYSIA COMPETENT CELLS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 308. MALAYSIA COMPETENT CELLS MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 309. MALAYSIA COMPETENT CELLS MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
TABLE 310. MALAYSIA COMPETENT CELLS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 311. MALAYSIA COMPETENT CELLS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 312. MALAYSIA COMPETENT CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 313. MALAYSIA COMPETENT CELLS MARKET SIZE, BY E. COLI COMPETENT CELLS, 2018-2030 (USD MILLION)
TABLE 314. MALAYSIA COMPETENT CELLS MARKET SIZE, BY MAMMALIAN COMPETENT CELLS, 2018-2030 (USD MILLION)
TABLE 315. MALAYSIA COMPETENT CELLS MARKET SIZE, BY OTHER BACTERIAL COMPETENT CELLS, 2018-2030 (USD MILLION)
TABLE 316. MALAYSIA COMPETENT CELLS MARKET SIZE, BY YEAST COMPETENT CELLS, 2018-2030 (USD MILLION)
TABLE 317. MALAYSIA COMPETENT CELLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 318. MALAYSIA COMPETENT CELLS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 319. MALAYSIA COMPETENT CELLS MARKET SIZE, BY BIOTECH COMPANIES, 2018-2030 (USD MILLION)
TABLE 320. MALAYSIA COMPETENT CELLS MARKET SIZE, BY PRODUCT OFFERINGS, 2018-2030 (USD MILLION)
TABLE 321. MALAYSIA COMPETENT CELLS MARKET SIZE, BY COMPETENT CELL KITS, 2018-2030 (USD MILLION)
TABLE 322. MALAYSIA COMPETENT CELLS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 323. MALAYSIA COMPETENT CELLS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 324. MALAYSIA COMPETENT CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 325. PHILIPPINES COMPETENT CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 326. PHILIPPINES COMPETENT CELLS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 327. PHILIPPINES COMPETENT CELLS MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 328. PHILIPPINES COMPETENT CELLS MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
TABLE 329. PHILIPPINES COMPETENT CELLS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 330. PHILIPPINES COMPETENT CELLS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 331. PHILIPPINES COMPETENT CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 332. PHILIPPINES COMPETENT CELLS MARKET SIZE, BY E. COLI COMPETENT CELLS, 2018-2030 (USD MILLION)
TABLE 333. PHILIPPINES COMPETENT CELLS MARKET SIZE, BY MAMMALIAN COMPETENT CELLS, 2018-2030 (USD MILLION)
TABLE 334. PHILIPPINES COMPETENT CELLS MARKET SIZE, BY OTHER BACTERIAL COMPETENT CELLS, 2018-2030 (USD MILLION)
TABLE 335. PHILIPPINES COMPETENT CELLS MARKET SIZE, BY YEAST COMPETENT CELLS, 2018-2030 (USD MILLION)
TABLE 336. PHILIPPINES COMPETENT CELLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 337. PHILIPPINES COMPETENT CELLS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 338. PHILIPPINES COMPETENT CELLS MARKET SIZE, BY BIOTECH COMPANIES, 2018-2030 (USD MILLION)
TABLE 339. PHILIPPINES COMPETENT CELLS MARKET SIZE, BY PRODUCT OFFERINGS, 2018-2030 (USD MILLION)
TABLE 340. PHILIPPINES COMPETENT CELLS MARKET SIZE, BY COMPETENT CELL KITS, 2018-2030 (USD MILLION)
TABLE 341. PHILIPPINES COMPETENT CELLS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 342. PHILIPPINES COMPETENT CELLS MARKE

Companies Mentioned

The leading players in the Competent Cells Market, which are profiled in this report, include:
  • Addgene
  • Agilent Technologies
  • Bio-Rad Laboratories
  • BioDynamics Laboratory
  • Bioneer Corporation
  • Cayman Chemical Company
  • Cell Applications
  • Edge BioSystems
  • GenScript Biotech
  • Lucigen Corporation
  • Merck Group
  • New England Biolabs
  • OriGene Technologies
  • Promega Corporation
  • QIAGEN
  • Scarab Genomics
  • Takara Bio
  • Thermo Fisher Scientific
  • Yeastern Biotech
  • Zymo Research

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages197
PublishedOctober 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 2.21 Billion
Forecasted Market Value ( USD ) by 2030 $ 3.62 Billion
Compound Annual Growth Rate8.7%
Regions CoveredGlobal
No. of Companies Mentioned21

Related Topics

Related Reports

Competent Cells Market Size, Share & Trends Analysis Report by Type (Chemically Competent Cells, Electrocompetent Cells, Ultracompetent Cells), Application (Cloning, Protein Expression, Mutagenesis), End-use, Region, and Segment Forecasts, 2024-2030 - Product Image

Competent Cells Market Size, Share & Trends Analysis Report by Type (Chemically Competent Cells, Electrocompetent Cells, Ultracompetent Cells), Application (Cloning, Protein Expression, Mutagenesis), End-use, Region, and Segment Forecasts, 2024-2030

  • Report
  • 120 Pages
  • Global
From
Competent Cells - Global Strategic Business Report - Product Image

Competent Cells - Global Strategic Business Report

  • Report
  • 196 Pages
  • Global
From
Competent Cells Market Report 2024 - Product Image

Competent Cells Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Competent Cells Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Image

Competent Cells Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • 185 Pages
  • Global
From
Competent Cells Market Size, Share & Trends Analysis Report By Type, By Application (Cloning, Protein Expression, Mutagenesis, and Others), By End-Use, By Regional Outlook and Forecast, 2024 - 2031 - Product Image

Competent Cells Market Size, Share & Trends Analysis Report By Type, By Application (Cloning, Protein Expression, Mutagenesis, and Others), By End-Use, By Regional Outlook and Forecast, 2024 - 2031

  • Report
  • 237 Pages
  • Global
From

About the Market

The Competent Cells market within the biotechnology industry is a specialized sector that focuses on the production of genetically modified cells. These cells are used in a variety of research and development applications, such as gene cloning, protein expression, and gene therapy. Competent cells are typically produced through a process of chemical or electrical transformation, which allows them to take up foreign DNA. This process is used to create a variety of genetically modified organisms, such as bacteria, yeast, and mammalian cells. The Competent Cells market is an important part of the biotechnology industry, as it provides researchers with the tools they need to develop new treatments and therapies. It is also a key component of the biomanufacturing industry, as it enables the production of biopharmaceuticals and other bioproducts. Some of the major companies in the Competent Cells market include Thermo Fisher Scientific, Merck KGaA, Promega Corporation, Agilent Technologies, and Lonza Group. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.